Hedge Fund - Lynx1 Capital Management
Cymabay Therapeutics Inc. (CBAY)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $17.81 |
2 | 2023 - Q3 (2023-09-30) | $14,822,941 | 9.8% | 994,161 | $13.26 |
3 | 2023 - Q2 (2023-06-30) | $13,195,298 | 8.64% | 1,205,050 | $9.31 |
4 | 2023 - Q1 (2023-03-31) | $11,945,763 | 9.95% | 1,369,927 | $8.01 |
5 | 2022 - Q4 (2022-12-31) | $10,367,414 | 8.96% | 1,653,495 | $3.80 |
6 | 2022 - Q3 (2022-09-30) | $8,140,000 | 7.34% | 2,325,833 | $3.59 |
7 | 2022 - Q2 (2022-06-30) | $7,640,000 | 6.5% | 2,589,679 | $2.39 |
8 | 2022 - Q1 (2022-03-31) | $4,318,000 | 4% | 1,388,505 | $3.15 |
9 | 2021 - Q4 (2021-12-31) | $4,140,000 | 3.61% | 1,224,968 | $3.80 |
The displayed share prices are average quarterly stock market prices.